EFCG Welcomes Action on APIs

The European Fine Chemicals Group (EFCG) told journalists at the CPhI expo in Frankfurt last week that enforcement against manufacturers of counterfeit medicines is “becoming much more effective.“ However, “we must continue to urge regulators to increase their efforts to deter the rogue players in the active pharma ingredients [API] supply chain,” Guy Villax, EFCG board member and CEO of Hovione (Lisbon), told journalists. “We are particularly looking forward to the European Commission’s legal proposal to combat counterfeit...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers